Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Pediatr Endocrinol Metab ; 34(4): 441-447, 2021 Apr 27.
Article in English | MEDLINE | ID: mdl-33639045

ABSTRACT

OBJECTIVES: Current treatment protocols in acute lymphoblastic leukemia (ALL) are associated with high remission rates and long life expectancy, enhancing the importance of quality of life and prevention of treatment-related complications in patient care. As osteoporosis is a frequent complication in patients under chemotherapy, we investigated the effect of vitamin K2 (100 mcg menaquinone-7) and vitamin D3 (10 mcg calcitriol) on bone metabolism in children with ALL. METHODS: Twenty-nine consecutive patients recently diagnosed with B precursor ALL (B-ALL) and treated according to the Turkish Acute Lymphoblastic Leukemia Berlin Frankfurt Münster 2000 protocol were randomly assigned into study and control groups. The study group (n=15, M/F: 8/7, age 1-14.5 years, mean 6.5 years) received vitamin K2 and vitamin D3 with their chemotherapy, while the control group (n=14, M/F 9/5, age 2-17 years, mean 7.1 years) received chemotherapy only. Serum calcium, phosphorus, magnesium, alkaline phosphatase, bone-specific alkaline phosphatase, uncarboxylated osteocalcin (ucOC), tartrate resistant acid phosphatase 5b, carboxyl terminal procollagen propeptide (PICP), osteoprotegerin (OPG), and receptor activator nuclear kappa B ligand (RANKL) were measured and bone mineral density (BMD) was determined at baseline and first, second, third and sixth months. RESULTS: The study group had higher serum OPG/RANKL ratio and lower ucOC levels compared to the control group at the first month; PICP levels were higher in the study group at second and third months. CONCLUSIONS: These results suggest an early beneficial effect of the combination of vitamin K2 and vitamin D3 on BMD in ALL patients especially during the period of intensive steroid therapy in the first months.


Subject(s)
Bone Density/drug effects , Cholecalciferol/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Vitamin K 2/therapeutic use , Vitamins/therapeutic use , Adolescent , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone and Bones/drug effects , Bone and Bones/metabolism , Child , Child, Preschool , Female , Gene Expression Regulation/drug effects , Humans , Infant , Male , Osteoporosis/chemically induced , Osteoporosis/drug therapy , Osteoprotegerin/biosynthesis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Procollagen/metabolism , Prospective Studies , RANK Ligand/biosynthesis
2.
Biol Trace Elem Res ; 186(1): 218-225, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29520723

ABSTRACT

Boron plays roles in the metabolism of calcium, vitamin D, steroid hormones, healthy bone development, and maintenance of cell membranes. The biological effects of boron are dose-dependent but follow a U-shaped pattern, rendering it important to define the active range. The studies of Bahadoran et al. on rats and Naghii et al. on humans showed that low doses of boron (3 and 10 mg/day) prevented kidney stone formation. The aim of this study was to determine whether high doses of boron have an anti-urolithiatic or antioxidant effect on nephrolithiasis in an experimental rat model. The study was conducted on 50 adult male Wistar rats randomized to five groups. Nephrolithiasis was induced with water containing 0.75% ethylene glycol (EG) and 2% ammonium chloride (AC). This treatment was given to animals in all groups for 10 days, except the positive and negative controls. Simultaneously, groups 2, 3, and 4 were given boric acid via gavage at doses of 25, 50, and 100 mg/kg/day (equivalent to 4/8/16 mg boron respectively) as the source of boron. Animals in the negative and positive control groups were given 6 µL/g distilled water without boric acid. At day 10, intra-cardiac blood samples were drawn from all animals. The right and left kidneys were removed for biochemical and histopathological examinations, respectively. The groups were compared with respect to serum urea, creatinine, calcium, phosphorous, total antioxidant status (TAS), total oxidant status (TOS), serum paraoxonase (PON1) activity, tissue calcium and oxalate levels, and stone burden as determined by histopathological examination. Serum urea and creatinine levels were significantly higher (p < 0.001 and p < 0.05, respectively), while serum calcium and phosphorous levels were significantly lower (p < 0.001 and p < 0.001, respectively), in animals given EG/AC compared to negative controls. No significant differences were detected in serum calcium, phosphorous, urea, or creatinine levels between animals treated with boron and positive controls (p > 0.05). Serum PON1 activity was significantly lower in animals given EG/AC than in negative controls (p < 0.001), while no significant difference in serum PON1 level was detected between rats treated with boron and positive controls. No significant differences were detected in vitamin D, TAS, TOS, tissue calcium, or tissue oxalate levels among groups. No stone formation was detected on histopathological examination in negative controls. No significant differences were found in stone formation between rats treated with boron and positive controls. Based on this study, high doses of boron had no protective effect against nephrolithiasis and oxidative stress.


Subject(s)
Disease Models, Animal , Nephrolithiasis , Oxidative Stress , Animals , Antioxidants/analysis , Antioxidants/metabolism , Boron/administration & dosage , Boron/pharmacology , Male , Rats , Rats, Wistar , Vitamin D/metabolism
3.
J Pediatr Hematol Oncol ; 35(8): 623-7, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24136015

ABSTRACT

Thalassemic osteopathy (TOSP) has emerged as a topic of interest, as the optimized transfusion regimens and iron chelations has markedly improved the survival of the patients suffering from thalassemia major (TM) and increased the life expectancy. The aim of this prospective monocentric pilot study was to investigate the effects of a dietary supplement with vitamin K2 (50 mcg menaquinone-7) and vitamin D (5 mcg calcitriol) on the patients with TOSP. Twenty children (12 girls, 8 boys; age varied from 3 to 18 y) with ß TM, who underwent regular blood transfusion and iron chelation therapy, were enrolled in this study and investigated at the initial, sixth, and 12th month of the treatment. We detected a significant improvement in the bone mineral density and Z-score at the lumbar spine area of the patients at the sixth and 12th month of the treatment, especially in the prepubertal group. We also found a decrease in the ratio of undercarboxylated osteocalcin to carboxylated osteocalcin, however, this was not found to be significant. Although the natural course of TOSP is worsening or at least stabilizing, our pilot study demonstrated that vitamin K2 and calcitriol combination clearly has a positive effect on the bone mineral density of the children with TM during a 1-year period. Supplementation of menaquinone-7 instead of drugs is an augmented physiological intake and seems a beneficial alternative for the treatment of TOSP. Further studies on a large number of participants are necessary to highlight the effect of vitamin K2 on TOSP.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Bone Diseases/prevention & control , Calcitriol/therapeutic use , Vitamin K 2/analogs & derivatives , beta-Thalassemia/complications , Absorptiometry, Photon , Adolescent , Bone Density/drug effects , Bone Diseases/etiology , Bone and Bones/drug effects , Chelation Therapy/adverse effects , Child , Female , Humans , Iron Chelating Agents/adverse effects , Male , Pilot Projects , Transfusion Reaction , Vitamin K 2/therapeutic use
4.
J Surg Res ; 151(1): 74-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18468627

ABSTRACT

BACKGROUND: During some surgical interventions, temporary occlusion of the hepatic blood supply may cause ischemia-reperfusion (IR) injury. Recent studies suggest that type 3 phosphodiesterase inhibitors may have a beneficial effect on liver IR injury. The aim of this study was to investigate whether amrinone, a type 3 phosphodiesterase inhibitor, could have a protective effect on liver having experimental liver IR injury. MATERIALS AND METHODS: Sixty Wistar albino rats were randomly divided into three groups. The IR and amrinone groups were subjected to 1 h total hepatic ischemia, followed by 2 h of reperfusion. The sham group underwent midline laparotomy only. Amrinone 10 microg/kg/min was infused to the amrinone group during the 3 h of the IR period. Histopathological examination, biochemical liver function, and liver adenosine triphosphate concentration after reperfusion and survival rate on the seventh day after the IR insult were recorded. RESULTS: Serum aspartate aminotransferase, alanine aminotransferase, lactic dehydrogenase levels, and histological damage scores in the amrinone and IR groups were significantly higher compared with the sham group (P < 0.01). However, all of these values were significantly lower in the amrinone group than in the IR group (P < 0.05). Liver adenosine triphosphate levels and the rat survival rate in the amrinone and IR groups were significantly lower than those in the sham group (P < 0.01). However, these values were significantly higher in the amrinone group compared to those in the IR group (P < 0.01). CONCLUSIONS: These results suggest that amrinone plays a significant role in the protection of liver against IR injury and that this treatment may be a novel pharmacological agent for safe and efficient liver surgery.


Subject(s)
Amrinone/pharmacology , Liver Diseases/prevention & control , Phosphodiesterase Inhibitors/pharmacology , Reperfusion Injury/prevention & control , Vasodilator Agents/pharmacology , Adenosine Triphosphate/metabolism , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Biopsy , Calcium/metabolism , Cyclic AMP/metabolism , Disease Models, Animal , L-Lactate Dehydrogenase/blood , Liver/blood supply , Liver/metabolism , Liver/pathology , Liver Diseases/metabolism , Male , Platelet Aggregation/drug effects , Rats , Rats, Wistar , Reperfusion Injury/metabolism
5.
Ulus Travma Acil Cerrahi Derg ; 14(4): 277-83, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18988050

ABSTRACT

BACKGROUND: To demonstrate the effect of piracetam on changes in brain tissue and serum nitric oxide levels in dogs submitted to hemorrhagic shock. METHODS: The subjects were randomized into four subgroups each consisting of 10 dogs. Hemorrhagic shock was induced in Group I for 1 hour and no treatment was given to this group. Blood and saline solutions were administered to Group II following 1 hour hemorrhagic shock. Blood and piracetam were given to Group III following 1 hour shock. No shock was induced and no treatment was applied to Group IV. Blood samples were obtained at the onset of the experiment and at 60, 120 and 180 minutes for nitric oxide analysis. For histopathological examination, brain tissue samples were obtained at the end of the experiment. RESULTS: The observed improvement in blood pressure and pulse rates in Group III was more than in Group II. Nitric oxide levels were increased in Group I; however, no correlation between piracetam and nitric oxide levels was determined. It was seen that recovery in brain damage in Group III was greater than in the control group. CONCLUSION: Piracetam, added to the treatment, may ecrease ischemic damage in hemorrhagic shock.


Subject(s)
Brain/drug effects , Brain/pathology , Neuroprotective Agents/pharmacology , Nitric Oxide/blood , Piracetam/pharmacology , Shock, Hemorrhagic/drug therapy , Analysis of Variance , Animals , Area Under Curve , Blood Pressure/drug effects , Blood Pressure/physiology , Disease Models, Animal , Dogs , Humans , Immunohistochemistry , Male , Random Allocation , Time Factors
6.
World J Gastroenterol ; 14(8): 1222-30, 2008 Feb 28.
Article in English | MEDLINE | ID: mdl-18300348

ABSTRACT

AIM: To investigate the effects of bombesin (BBS) and neurotensin (NTS) on apoptosis and colitis in an ulcerative colitis model. METHODS: In this study, a total of 50 rats were divided equally into 5 groups. In the control group, no colitis induction or drug administration was performed. Colitis was induced in all other groups. Following the induction of colitis, BBS, NTS or both were applied to three groups of rats. The remaining group (colitis group) received no treatment. On the 11th d after induction of colitis and drug treatment, blood samples were collected for TNF-alpha and IL-6 level studies. Malondialdehyde (MDA), carbonyl, myeloperoxidase (MPO) and caspase-3 activities, as well as histopathological findings, evaluated in colonic tissues. RESULTS: According to the macroscopic and microscopic findings, the study groups treated with BBS, NTS and BBS + NTS showed significantly lower damage and inflammation compared with the colitis group (macroscopic score, 2.1 +/- 0.87, 3.7 +/- 0.94 and 2.1 +/- 0.87 vs 7.3 +/- 0.94; microscopic score, 2.0 +/- 0.66, 3.3 +/- 0.82 and 1.8 +/- 0.63 vs 5.2 +/- 0.78, P < 0.01). TNF-alpha and IL-6 levels were increased significantly in all groups compared with the control group. These increases were significantly smaller in the BBS, NTS and BBS + NTS groups compared with the colitis group (TNF-alpha levels, 169.69 +/- 53.56, 245.86 +/- 64.85 and 175.54 +/- 42.19 vs 556.44 +/- 49.82; IL-6 levels, 443.30 +/- 53.99, 612.80 +/- 70.39 and 396.80 +/- 78.43 vs 1505.90 +/- 222.23, P < 0.05). The colonic MPO and MDA levels were significantly lower in control, BBS, NTS and BBS + NTS groups than in the colitis group (MPO levels, 24.36 +/- 8.10, 40.51 +/- 8.67 and 25.83 +/- 6.43 vs 161.47 +/- 38.24; MDA levels, 4.70 +/- 1.41, 6.55 +/- 1.12 and 4.51 +/- 0.54 vs 15.60 +/- 1.88, P < 0.05). Carbonyl content and caspase-3 levels were higher in the colitis and NTS groups than in control, BBS and BBS + NTS groups (carbonyl levels, 553.99 +/- 59.58 and 336.26 +/- 35.72 vs 209.76 +/- 30.92, 219.76 +/- 25.77 and 220.34 +/- 36.95; caspase-3 levels, 451.70 +/- 68.27 and 216.20 +/- 28.17 vs 28.60 +/- 6.46, 170.50 +/- 32.37 and 166.50 +/- 30.95, P < 0.05). CONCLUSION: The results of this study suggest BBS and NTS, through their anti-inflammatory actions, support the maintenance of colonic integrity and merit consideration as potential agents for ameliorating colonic inflammation.


Subject(s)
Apoptosis , Bombesin/pharmacology , Colitis/chemically induced , Neurotensin/pharmacology , Trinitrobenzenesulfonic Acid/adverse effects , Animals , Caspase 3/metabolism , Colon/pathology , Interleukin-6/blood , Interleukin-6/metabolism , Male , Malondialdehyde/metabolism , Oxidative Stress , Peroxidase/metabolism , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/blood
7.
Coron Artery Dis ; 18(8): 633-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18004114

ABSTRACT

OBJECTIVE: The diagnosis of coronary artery disease (CAD) is an important clinical problem. Ischemia-modified albumin (IMA) has been demonstrated to be a helpful marker in detecting myocardial ischemia. In this study, we have investigated the diagnostic importance of IMA in CAD. METHOD AND RESULTS: Fifty patients with chest pain were enrolled in the study. IMA levels were measured on admission and within 30-60 min after exercise by albumin cobalt-binding test. Coronary angiography was performed in all patients after the exercise test. The mean preexercise IMA level was 83+/-27 U/ml in the patient group. IMA levels before the exercise test were similar in both patient and control groups (P>0.05). The mean IMA level in the patient group was, however, higher than in the control group after the exercise test (P=0.001). The sensitivity, specificity and positive and negative predictive values of the postexercise IMA levels >85 in diagnosis of CAD were 78, 73, 0.81 and 0.73%; respectively. Postexercise IMA levels were higher in patients with chest pain, ST depression and downsloping and horizontal ST depression of 2 mm or more. CONCLUSION: IMA levels after the exercise test increased in patients with CAD. Our study results indicate that postexercise IMA levels can be helpful markers in the diagnosis of stable CAD in clinical practice.


Subject(s)
Albumins/metabolism , Coronary Artery Disease/diagnosis , Myocardial Ischemia/metabolism , Aged , Exercise Test , Female , Humans , Male , Middle Aged , Sensitivity and Specificity
8.
J Surg Res ; 136(2): 280-7, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17046790

ABSTRACT

BACKGROUND: Transforming growth factor (TGF) beta is a potent inhibitor of hepatocyte DNA synthesis and liver regeneration. TGF-beta(1) expression progressively increases in obstructive jaundice. We investigated the effect of TGF-beta(1) blockage on liver regeneration in rats induced with obstructive jaundice. MATERIALS AND METHODS: Male Wistar-albino rats were divided into three groups: sham, control, and study groups. In the study and control groups, the common bile duct was ligated and divided, and 7 days later a partial hepatectomy was performed. In the study group, anti-TGF-beta(1) monoclonal antibody (10-microg single dose) was administered immediately after the 70% hepatectomy. In the control group, those rats in which obstructive jaundice was induced received normal saline after the 70% hepatectomy, and nonjaundiced rats received anti-TGF-beta(1) monoclonal antibody after the 70% hepatectomy. Rats were sacrificed after 48 or 72 h. Relative liver weight, AST, ALT, total and conjugated bilirubin, and TGF-beta(1) levels were measured. The mitotic index and proliferating cell nuclear antigen (PCNA) labeling index were evaluated as histopathologic parameters. RESULTS: At 72 h, the TGF-beta(1) level in the study group was similar to that in the sham group, whereas TGF-beta(1) in the study group was significantly lower than that of the jaundiced control group at 48 or 72 h (P < 0.001). The relative liver weight, mitotic index, and PCNA labeling index were significantly higher in the study group than in the jaundiced control group at 48 and 72 h (P < 0.001). The AST, ALT, and TGF-beta(1) levels were significantly higher in the jaundiced control group compared to the study group after 48 and 72 h, whereas these values were significantly lower in the nonjaundiced control group (P < 0.001). CONCLUSIONS: In obstructive jaundiced rats, TGF-beta(1) blockage with anti-TGF-beta(1) monoclonal antibody after liver resection improved liver regeneration both morphologically and functionally.


Subject(s)
Antibodies, Monoclonal/pharmacology , Hepatectomy/methods , Immunologic Factors/pharmacology , Jaundice, Obstructive/drug therapy , Liver Regeneration/immunology , Transforming Growth Factor beta1/immunology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Bilirubin/blood , Cell Division , DNA/biosynthesis , Hepatocytes/cytology , Jaundice, Obstructive/immunology , Male , Mitosis , Proliferating Cell Nuclear Antigen/metabolism , Rats , Rats, Wistar , Transforming Growth Factor beta1/blood
9.
Am J Surg ; 191(1): 77-83, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16399111

ABSTRACT

BACKGROUND: During colitis, epithelial function is impaired, leading to increased bacterial translocation. Recent studies have shown the important role of proinflammatory cytokines and chemokines, including RANTES (regulated on activation, normal T-cell expressed and secreted), in inflammatory bowel diseases (IBDs). In this study, we evaluated the role of Met-RANTES, an antagonist of the RANTES receptor, on the impairment of bacterial translocation in a rat model of colitis. METHODS: Rats were randomly assigned to 3 groups. Group 1 = control, group 2 = experimental colitis, and group 3 = colitis plus Met-RANTES treatment. On day 7 after colitis was induced, plasma tumor necrosis factor-alpha colon tissue myeloperoxidase and portal blood endotoxin levels were measured. Lymph node, liver, and spleen culture quantified bacterial translocation. RESULTS: Met-RANTES treatment resulted in significant decreases in colonic damage as well as bacterial translocation in experimental colitis. CONCLUSIONS: These results suggest that chemokine receptor antagonists may potentially be useful in the treatment of IBDs.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Bacterial Translocation/drug effects , Chemokine CCL5/analogs & derivatives , Colitis/physiopathology , Colon/drug effects , Animals , Chemokine CCL5/pharmacology , Colitis/chemically induced , Colitis/microbiology , Disease Models, Animal , Male , Noxae/adverse effects , Rats , Rats, Wistar , Trinitrobenzenesulfonic Acid/adverse effects
10.
J Surg Res ; 130(1): 66-72, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16154150

ABSTRACT

BACKGROUND: The phosphodiesterase inhibitors (PDEIs) have been proposed to improve hepatic reperfusion injury and hepatosplanchnic circulation, but the effects of these agents on liver regeneration have not been investigated thoroughly. The aim of this study was to investigate the effect of amrinone, a PDEI, on liver regeneration in rats. MATERIALS AND METHODS: Sixty rats were divided into two groups, control and amrinone. Each group was then divided into three groups (n=10). An infusion of amrinone to the study group and of 0.9% NaCl to the control group was performed. Seventy percent liver resection was performed to the rats during the first hour of infusion. The infusion was maintained for 17 h after resection. A total of 18 h infusion was performed. Rats were allowed to survive for 24, 48, and 72 h, and then they were sacrificed. Biochemical, morphological, hematological, and histopathologic measurements and assessments were performed. RESULTS: There were statistically significant differences between the amrinone and control groups in alkaline phosphatase and relative liver weights at 24, 48, and 72 h (P<0.05). There also were statistically significant differences between the groups in AST, bilirubin, and albumine levels at 24 h, ALT and prothrombine time levels at 48 h, and aspartate aminotransferase and alanine aminotransferase levels at 72 h (P<0.05). Hepatic ATP levels, mitotic index, and proliferating cell nuclear antigen labeling index were significantly higher in amrinone group compared with control group at all three time intervals (P<0.05). CONCLUSIONS: Amrinone improves both morphological and functional liver regeneration after liver resection.


Subject(s)
Amrinone/pharmacology , Hepatectomy , Liver Regeneration/drug effects , Phosphodiesterase Inhibitors/pharmacology , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Animals , Aspartate Aminotransferases/blood , Bilirubin/blood , Liver/anatomy & histology , Male , Models, Animal , Organ Size , Rats , Rats, Wistar , Serum Albumin
11.
J Surg Res ; 128(1): 15-20, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15975592

ABSTRACT

BACKGROUND: After surgical resection for colorectal carcinoma there is a high recurrence rate and, therefore, adjuvant chemotherapy may be useful in some patients. 5-Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent in the management of patients with colorectal cancer. However, gastrointestinal injury induced by chemotherapeutic agents may result in bacterial translocation from the gut into the systemic circulation. Granulocyte macrophage-colony stimulating factor (GM-CSF) may be used to prevent this side effect by means of macrophage activity stimulation. MATERIALS AND METHODS: A total of 45 rats were divided into three groups. Control group received intraperitoneal saline solution, 5-FU and GM-CSF groups received 50 mg/kg/day 5-FU intravenous infusion and GM-CSF group also received 200 ng/day GM-CSF subcutaneously for 6 days. Intestinal tissue was also sampled for pathological examination at day 7. Plasma levels of tumor necrosis factor-alpha and interleukin-6 were determined, bacterial translocation was quantified by lymph node, liver and spleen culture, and plasma endotoxin content was measured. RESULTS: White blood cell counts of the 5-FU rats were significantly lower than in the control and GM-CSF groups (P < 0.01). The plasma endotoxin, tumor necrosis factor-alpha and interleukin-6 levels in the 5-FU and GM-CSF groups were significantly increased at day 7 compared with the control groups (P < 0.01), but these levels were significantly lower in the GM-CSF group compared to the 5-FU group (P < 0.01). 5-FU intervention caused significant increase in the frequencies of bacterial translocation at liver, spleen, mesenteric lymph node, and portal blood. Compared with 5-FU group, GM-CSF decreased the bacterial translocation (P < 0.01). CONCLUSIONS: This study observed that the administration of 5-FU resulted in bacterial translocation. Activation of inflammatory response with GM-CSF is highly effective in prevention of bacterial translocation in 5-FU interventions.


Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Bacterial Translocation/drug effects , Fluorouracil/pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Growth Substances/pharmacology , Animals , Bacterial Translocation/physiology , Endotoxins/blood , Ileum/microbiology , Interleukin-6/blood , Male , Mononuclear Phagocyte System/microbiology , Rats , Tumor Necrosis Factor-alpha/analysis
12.
J Surg Res ; 122(1): 96-102, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15522321

ABSTRACT

BACKGROUND: Reperfusion of the liver after ischemia induces the expression of the heat shock genes and the synthesis of the heat shock proteins (HSP). We studied the effects of the natural antioxidant ergothioneine (EGT) treatment on the expression of HSP70 in ischemic-reperfused (IR) liver. METHODS: Adult male Wistar rats were randomly divided into three groups: Sham group given standard laboratory chow and water for 3 weeks followed by sham operation; Control group given standard laboratory chow and water for 3 weeks followed by liver IR injury; EGT group given standard laboratory chow supplementation l-ergothioneine (1.2 mg/kg/d body weight) administered by gavage and water for 3 weeks followed by liver IR injury. Ten rats from each group were killed to determine serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactic dehydrogenase (LDH), tissue malondialdehyde (MDA), HSP70 levels, and histologic changes at 30, 60, and 120 min of reperfusion, respectively. Survival was followed for 1 week. RESULTS: IR caused significant increase in serum AST, ALT, LDH, and tissue MDA levels. As compared with the control group, animals treated with EGT experienced a significant decrease in serum AST, ALT, and LDH levels in all reperfusion periods. Tissue MDA levels in animals receiving EGT were significantly reduced as compared with control group at 30 min and 60 min after reperfusion. After ischemia, reperfusion caused a remarkable production of HSP70 in the control group. When the rats were pretreated with EGT, the levels of HSP70 increased significantly in their livers after reperfusion compared with the control group. Liver injury in the EGT-treated animals was lower to that in the control group. The 7-day survival rate was significantly improved (from 50% to 80%) by EGT pretreatment. CONCLUSION: HSP70 has been shown to induce tolerance against warm IR injury in rat livers. EGT pretreatment protects the liver from IR injury by over-expression of HSP and the subsequent suppression of lipid peroxidation.


Subject(s)
Antioxidants/pharmacology , Ergothioneine/pharmacology , HSP70 Heat-Shock Proteins/metabolism , Liver Circulation , Liver/drug effects , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Alanine Transaminase/antagonists & inhibitors , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/antagonists & inhibitors , Aspartate Aminotransferases/blood , Cytoprotection , HSP70 Heat-Shock Proteins/antagonists & inhibitors , Immunohistochemistry/methods , L-Lactate Dehydrogenase/antagonists & inhibitors , L-Lactate Dehydrogenase/blood , Lipid Peroxidation/drug effects , Liver/pathology , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/blood , Rats , Rats, Wistar , Staining and Labeling , Survival Analysis
13.
Ulus Travma Derg ; 8(2): 112-7, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12038019

ABSTRACT

BACKGROUND: There are controversies on determination of trauma severity and on predicting effects of trauma severity on organism in patients with multiple trauma. It is of great importance to rule out these controversies in Turkey where incidence of multiple trauma due to traffic accidents is considerably high. The aim of our study was to investigate whether a correlation exists between trauma severity and plasma levels of nitric oxide and thiobarbituric acid reactive substance in patients with multiple trauma. METHODS: The patients with multiple trauma were divided into two groups as the study group (TRISS score 30 or above) and the control group (TRISS score below 30) and the relationship between plasma NO and TBARS levels was evaluated. In our study, we used the TRISS trauma score (Revised Trauma Score, Injury Severity Score and Age Combination Index) to evaluate trauma severity. RESULTS: There was no effect of trauma severity on plasma NO levels (p > 0.05). There was a positive correlation between TRISS scores and plasma TBARS levels (p < 0.05). CONCLUSIONS: It can be suggested that measurement of plasma NO levels is not useful to indicate trauma severity because change in TRISS is not associated with a correlated change in plasma NO levels. On the other hand, there is a significant correlation between plasma TBARS levels and increase in trauma severity.


Subject(s)
Multiple Trauma/diagnosis , Nitric Oxide/blood , Thiobarbituric Acid Reactive Substances/metabolism , Accidents, Traffic , Adolescent , Adult , Aged , Biomarkers/blood , Female , Humans , Injury Severity Score , Male , Middle Aged , Multiple Trauma/blood , Predictive Value of Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...